$ENZ Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ENZO BIOCHEM INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ENZO BIOCHEM INC. Get notifications about new insider transactions in ENZO BIOCHEM INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 17 2021 | ENZ | ENZO BIOCHEM INC | HARBERT MANAGEMENT CORP | 10% Owner | Sell | S | 4.54 | 100,000 | 453,900 | 5,175,913 | 5.3 M to 5.2 M (-1.90 %) |
Mar 17 2021 | ENZ | ENZO BIOCHEM INC | HARBERT MANAGEMENT CORP | 10% Owner | Sell | S | 4.70 | 200,000 | 940,000 | 5,275,913 | 5.5 M to 5.3 M (-3.65 %) |
Mar 17 2021 | ENZ | ENZO BIOCHEM INC | HARBERT MANAGEMENT CORP | 10% Owner | Sell | S | 5.00 | 44,768 | 223,840 | 5,475,913 | 5.5 M to 5.5 M (-0.81 %) |
Mar 17 2021 | ENZ | ENZO BIOCHEM INC | HARBERT MANAGEMENT CORP | 10% Owner | Sell | S | 4.75 | 100,000 | 475,000 | 5,520,681 | 5.6 M to 5.5 M (-1.78 %) |
Jan 13 2021 | ENZ | ENZO BIOCHEM INC | TAGLIAFERRI MARY | Director | Option Exercise | A | 2.63 | 77,101 | 202,776 | 77,101 | |
Jan 13 2021 | ENZ | ENZO BIOCHEM INC | TAGLIAFERRI MARY | Director | Option Exercise | A | 2.63 | 77,101 | 202,776 | 77,101 | |
Jan 13 2021 | ENZ | ENZO BIOCHEM INC | WEINER BARRY W | PRESIDENT AND TREAS ... | Grant | A | 0.00 | 142,586 | 0 | 1,657,499 | 1.5 M to 1.7 M (+9.41 %) |
Jan 13 2021 | ENZ | ENZO BIOCHEM INC | WEINER BARRY W | PRESIDENT AND TREAS ... | Grant | A | 0.00 | 142,586 | 0 | 1,657,499 | 1.5 M to 1.7 M (+9.41 %) |
Jan 13 2021 | ENZ | ENZO BIOCHEM INC | Fischer Rebecca J. | Director | Option Exercise | A | 2.63 | 77,101 | 202,776 | 160,434 | |
Jan 13 2021 | ENZ | ENZO BIOCHEM INC | RABBANI ELAZAR | CHIEF EXECUTIVE OFF ... | Grant | A | 0.00 | 190,114 | 0 | 2,262,208 | 2.1 M to 2.3 M (+9.17 %) |
Jan 13 2021 | ENZ | ENZO BIOCHEM INC | Perlysky Dov | Director | Option Exercise | A | 2.63 | 77,101 | 202,776 | 335,780 | |
Jan 13 2021 | ENZ | ENZO BIOCHEM INC | Fischer Rebecca J. | Director | Option Exercise | A | 2.63 | 77,101 | 202,776 | 160,434 | |
Jan 13 2021 | ENZ | ENZO BIOCHEM INC | Bench David | CHIEF FINANCIAL OFF ... | Option Exercise | A | 2.63 | 55,400 | 145,702 | 110,800 | |
Jan 13 2021 | ENZ | ENZO BIOCHEM INC | Walters Ian B. | Director | Option Exercise | A | 2.63 | 77,101 | 202,776 | 77,101 | |
Jan 13 2021 | ENZ | ENZO BIOCHEM INC | RABBANI ELAZAR | CHIEF EXECUTIVE OFF ... | Grant | A | 0.00 | 190,114 | 0 | 2,262,208 | 2.1 M to 2.3 M (+9.17 %) |
Jan 13 2021 | ENZ | ENZO BIOCHEM INC | Perlysky Dov | Director | Option Exercise | A | 2.63 | 77,101 | 202,776 | 335,780 | |
Jan 13 2021 | ENZ | ENZO BIOCHEM INC | Bench David | CHIEF FINANCIAL OFF ... | Option Exercise | A | 2.63 | 55,400 | 145,702 | 110,800 | |
Jan 13 2021 | ENZ | ENZO BIOCHEM INC | Walters Ian B. | Director | Option Exercise | A | 2.63 | 77,101 | 202,776 | 77,101 | |
Apr 29 2020 | ENZ | ENZO BIOCHEM INC | BLANK FABIAN | Director | Option Exercise | A | 2.65 | 83,333 | 220,832 | 83,333 | |
Apr 29 2020 | ENZ | ENZO BIOCHEM INC | BLANK FABIAN | Director | Option Exercise | A | 2.65 | 83,333 | 220,832 | 83,333 | |
Apr 28 2020 | ENZ | ENZO BIOCHEM INC | CLEMENS PETER J IV | Director | Option Exercise | A | 2.65 | 83,333 | 220,832 | 98,333 | |
Apr 28 2020 | ENZ | ENZO BIOCHEM INC | Fischer Rebecca J. | Director | Option Exercise | A | 2.65 | 83,333 | 220,832 | 83,333 | |
Apr 28 2020 | ENZ | ENZO BIOCHEM INC | Perlysky Dov | Director | Option Exercise | A | 2.65 | 83,333 | 220,832 | 258,679 | |
Feb 26 2020 | ENZ | ENZO BIOCHEM INC | Bench David | CHIEF FINANCIAL OFF ... | Option Exercise | A | 2.20 | 55,400 | 121,880 | 55,400 | |
Feb 26 2020 | ENZ | ENZO BIOCHEM INC | RABBANI ELAZAR | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 2.20 | 130,100 | 286,220 | 310,715 | |
Feb 26 2020 | ENZ | ENZO BIOCHEM INC | WEINER BARRY W | PRESIDENT AND TREAS ... | Option Exercise | A | 2.20 | 116,900 | 257,180 | 268,389 | |
Feb 19 2020 | ENZ | ENZO BIOCHEM INC | CLEMENS PETER J IV | 10% Owner | Buy | P | 2.20 | 4,000 | 8,800 | 15,000 | 11 K to 15 K (+36.36 %) |
Feb 19 2020 | ENZ | ENZO BIOCHEM INC | CLEMENS PETER J IV | 10% Owner | Buy | P | 2.21 | 6,000 | 13,260 | 11,000 | 5 K to 11 K (+120.00 %) |
Aug 20 2019 | ENZ | ENZO BIOCHEM INC | HARBERT MANAGEMENT CORP | 10% Owner | Buy | P | 3.11 | 9,700 | 30,167 | 5,620,681 | 5.6 M to 5.6 M (+0.17 %) |
Aug 20 2019 | ENZ | ENZO BIOCHEM INC | HARBERT MANAGEMENT CORP | 10% Owner | Buy | P | 3.06 | 22,800 | 69,768 | 5,610,981 | 5.6 M to 5.6 M (+0.41 %) |
Jul 24 2019 | ENZ | ENZO BIOCHEM INC | HARBERT MANAGEMENT CORP | 10% Owner | Buy | P | 3.65 | 409,200 | 1,493,580 | 5,588,181 | 5.2 M to 5.6 M (+7.90 %) |
Jul 24 2019 | ENZ | ENZO BIOCHEM INC | HARBERT MANAGEMENT CORP | 10% Owner | Buy | P | 3.64 | 9,644 | 35,104 | 5,178,981 | 5.2 M to 5.2 M (+0.19 %) |
May 30 2019 | ENZ | ENZO BIOCHEM INC | HARBERT MANAGEMENT CORP | 10% Owner | Buy | P | 3.07 | 19,391 | 59,530 | 5,169,337 | 5.1 M to 5.2 M (+0.38 %) |
May 30 2019 | ENZ | ENZO BIOCHEM INC | HARBERT MANAGEMENT CORP | 10% Owner | Buy | P | 3.08 | 19,050 | 58,674 | 5,149,946 | 5.1 M to 5.1 M (+0.37 %) |
May 30 2019 | ENZ | ENZO BIOCHEM INC | HARBERT MANAGEMENT CORP | 10% Owner | Buy | P | 3.06 | 13,677 | 41,852 | 5,130,896 | 5.1 M to 5.1 M (+0.27 %) |
May 30 2019 | ENZ | ENZO BIOCHEM INC | HARBERT MANAGEMENT CORP | 10% Owner | Buy | P | 3.10 | 50,000 | 155,000 | 5,117,219 | 5.1 M to 5.1 M (+0.99 %) |
May 22 2019 | ENZ | ENZO BIOCHEM INC | HARBERT MANAGEMENT CORP | 10% Owner | Buy | P | 3.61 | 14,132 | 51,017 | 5,067,219 | 5.1 M to 5.1 M (+0.28 %) |
May 22 2019 | ENZ | ENZO BIOCHEM INC | HARBERT MANAGEMENT CORP | 10% Owner | Buy | P | 3.61 | 14,132 | 51,017 | 5,067,219 | 5.1 M to 5.1 M (+0.28 %) |
Jan 18 2019 | ENZ | ENZO BIOCHEM INC | RABBANI ELAZAR | Chm of the Bd, CEO ... | Option Exercise | M | 2.70 | 41,634 | 112,412 | 180,615 | |
Jan 18 2019 | ENZ | ENZO BIOCHEM INC | RABBANI ELAZAR | Chm of the Bd, CEO ... | Buy | M | 2.70 | 2,782 | 7,511 | 1,661,003 | 1.7 M to 1.7 M (+0.17 %) |
Jan 18 2019 | ENZ | ENZO BIOCHEM INC | Perlysky Dov | Director | Option Exercise | M | 2.70 | 64,286 | 173,572 | 175,346 | |
Jan 18 2019 | ENZ | ENZO BIOCHEM INC | Perlysky Dov | Director | Buy | M | 2.70 | 9,184 | 24,797 | 65,787 | 56.6 K to 65.8 K (+16.23 %) |
Jan 18 2019 | ENZ | ENZO BIOCHEM INC | BORTZ GREGORY M. | Director | Option Exercise | M | 2.70 | 64,286 | 173,572 | 175,346 | |
Jan 18 2019 | ENZ | ENZO BIOCHEM INC | BORTZ GREGORY M. | Director | Buy | M | 2.70 | 9,184 | 24,797 | 93,699 | 84.5 K to 93.7 K (+10.87 %) |
Jan 18 2019 | ENZ | ENZO BIOCHEM INC | WEINER BARRY W | Pres, CFO Prin Acct ... | Option Exercise | M | 2.70 | 33,305 | 89,924 | 151,489 | |
Jan 18 2019 | ENZ | ENZO BIOCHEM INC | WEINER BARRY W | Pres, CFO Prin Acct ... | Buy | M | 2.70 | 2,226 | 6,010 | 1,136,918 | 1.1 M to 1.1 M (+0.20 %) |
Jan 04 2019 | ENZ | ENZO BIOCHEM INC | O'Brien James Michael | EVP of Finance | Option Exercise | A | 2.80 | 52,000 | 145,600 | 33,666 | |
Jan 04 2019 | ENZ | ENZO BIOCHEM INC | WEINER BARRY W | Pres, CFO Prin Acct ... | Option Exercise | A | 2.80 | 115,000 | 322,000 | 184,794 | |
Jan 04 2019 | ENZ | ENZO BIOCHEM INC | RABBANI ELAZAR | Chm of the Bd, CEO ... | Option Exercise | A | 2.80 | 128,000 | 358,400 | 222,249 | |
Jan 04 2019 | ENZ | ENZO BIOCHEM INC | BORTZ GREGORY M. | Director | Option Exercise | A | 2.80 | 94,607 | 264,900 | 239,632 | |
Jan 04 2019 | ENZ | ENZO BIOCHEM INC | Perlysky Dov | Director | Option Exercise | A | 2.80 | 94,607 | 264,900 | 239,632 | |
Jan 04 2019 | ENZ | ENZO BIOCHEM INC | Hanna Bruce A. | Director | Option Exercise | A | 2.80 | 94,607 | 264,900 | 43,632 | |
Oct 31 2018 | ENZ | ENZO BIOCHEM INC | RABBANI ELAZAR | Chm of the Bd, CEO ... | Buy | P | 3.35 | 10,000 | 33,469 | 1,848,668 | 1.8 M to 1.8 M (+0.54 %) |
Oct 22 2018 | ENZ | ENZO BIOCHEM INC | Perlysky Dov | Director | Buy | P | 3.50 | 10,000 | 35,000 | 266,235 | 256.2 K to 266.2 K (+3.90 %) |
Oct 22 2018 | ENZ | ENZO BIOCHEM INC | Hanna Bruce A. | Director | Buy | P | 3.52 | 15,000 | 52,787 | 37,816 | 22.8 K to 37.8 K (+65.74 %) |
Aug 20 2018 | ENZ | ENZO BIOCHEM INC | Perlysky Dov | Director | Buy | J | 0.00 | 81,855 | 0 | 779,692 | 697.8 K to 779.7 K (+11.73 %) |
Aug 20 2018 | ENZ | ENZO BIOCHEM INC | Perlysky Dov | Director | Buy | J | 0.00 | 3,139 | 0 | 697,837 | 694.7 K to 697.8 K (+0.45 %) |
Aug 02 2018 | ENZ | ENZO BIOCHEM INC | O'Brien James Michael | EVP of Finance | Option Exercise | A | 4.42 | 35,000 | 154,700 | 23,666 | |
Aug 02 2018 | ENZ | ENZO BIOCHEM INC | WEINER BARRY W | Pres, CFO Prin Acct ... | Option Exercise | A | 4.42 | 80,000 | 353,600 | 152,294 | |
Aug 02 2018 | ENZ | ENZO BIOCHEM INC | RABBANI ELAZAR | Chm of the Bd, CEO ... | Option Exercise | A | 4.42 | 90,000 | 397,800 | 184,749 | |
Jan 19 2018 | ENZ | ENZO BIOCHEM INC | WEINER BARRY W | President, CFO, Tre ... | Option Exercise | M | 2.88 | 30,802 | 88,710 | 184,794 | |
Jan 19 2018 | ENZ | ENZO BIOCHEM INC | WEINER BARRY W | President, CFO, Tre ... | Payment of Exercise | F | 7.75 | 11,626 | 90,102 | 1,290,485 | 1.3 M to 1.3 M (-0.89 %) |
Jan 19 2018 | ENZ | ENZO BIOCHEM INC | WEINER BARRY W | President, CFO, Tre ... | Sell | S | 7.75 | 11,000 | 85,250 | 1,302,111 | 1.3 M to 1.3 M (-0.84 %) |
Jan 19 2018 | ENZ | ENZO BIOCHEM INC | WEINER BARRY W | President, CFO, Tre ... | Buy | M | 2.88 | 30,802 | 88,710 | 1,313,111 | 1.3 M to 1.3 M (+2.40 %) |
Jan 19 2018 | ENZ | ENZO BIOCHEM INC | RABBANI ELAZAR | CEO, Chn. of the Br ... | Option Exercise | M | 2.88 | 38,505 | 110,894 | 222,249 | |
Jan 19 2018 | ENZ | ENZO BIOCHEM INC | RABBANI ELAZAR | CEO, Chn. of the Br ... | Payment of Exercise | F | 7.75 | 14,534 | 112,639 | 1,838,668 | 1.9 M to 1.8 M (-0.78 %) |
Jan 19 2018 | ENZ | ENZO BIOCHEM INC | RABBANI ELAZAR | CEO, Chn. of the Br ... | Sell | S | 7.75 | 14,000 | 108,500 | 1,853,202 | 1.9 M to 1.9 M (-0.75 %) |
Jan 19 2018 | ENZ | ENZO BIOCHEM INC | RABBANI ELAZAR | CEO, Chn. of the Br ... | Buy | M | 2.88 | 38,505 | 110,894 | 1,867,202 | 1.8 M to 1.9 M (+2.11 %) |
Jan 09 2018 | ENZ | ENZO BIOCHEM INC | Hanna Bruce A. | Director | Option Exercise | A | 8.36 | 36,860 | 308,150 | 80,492 | |
Jan 09 2018 | ENZ | ENZO BIOCHEM INC | BORTZ GREGORY M. | Director | Option Exercise | A | 8.36 | 36,860 | 308,150 | 276,492 | |
Jan 09 2018 | ENZ | ENZO BIOCHEM INC | Perlysky Dov | Director | Option Exercise | A | 8.36 | 36,860 | 308,150 | 276,492 | |
Nov 02 2017 | ENZ | ENZO BIOCHEM INC | Perlysky Dov | Director | Option Exercise | M | 2.88 | 59,455 | 171,230 | 239,632 | |
Nov 02 2017 | ENZ | ENZO BIOCHEM INC | Perlysky Dov | Director | Sell | S | 9.81 | 42,000 | 412,020 | 642,237 | 684.2 K to 642.2 K (-6.14 %) |
Nov 02 2017 | ENZ | ENZO BIOCHEM INC | Perlysky Dov | Director | Buy | M | 2.88 | 59,455 | 171,230 | 684,237 | 624.8 K to 684.2 K (+9.52 %) |
Nov 02 2017 | ENZ | ENZO BIOCHEM INC | BORTZ GREGORY M. | Director | Option Exercise | M | 2.88 | 59,455 | 171,230 | 239,632 | |
Nov 02 2017 | ENZ | ENZO BIOCHEM INC | BORTZ GREGORY M. | Director | Sell | S | 9.82 | 42,005 | 412,489 | 250,870 | 292.9 K to 250.9 K (-14.34 %) |
Nov 02 2017 | ENZ | ENZO BIOCHEM INC | BORTZ GREGORY M. | Director | Buy | M | 2.88 | 59,455 | 171,230 | 292,875 | 233.4 K to 292.9 K (+25.47 %) |
Oct 30 2017 | ENZ | ENZO BIOCHEM INC | O'Brien James Michael | EVP of Finance | Option Exercise | M | 4.35 | 8,667 | 37,701 | 52,334 | |
Oct 30 2017 | ENZ | ENZO BIOCHEM INC | O'Brien James Michael | EVP of Finance | Option Exercise | M | 3.40 | 7,500 | 25,500 | 61,001 | |
Oct 30 2017 | ENZ | ENZO BIOCHEM INC | O'Brien James Michael | EVP of Finance | Option Exercise | M | 2.75 | 6,699 | 18,422 | 68,501 | |
Oct 30 2017 | ENZ | ENZO BIOCHEM INC | O'Brien James Michael | EVP of Finance | Sell | S | 10.28 | 8,667 | 89,097 | 28,187 | 36.9 K to 28.2 K (-23.52 %) |
Oct 30 2017 | ENZ | ENZO BIOCHEM INC | O'Brien James Michael | EVP of Finance | Sell | S | 10.28 | 7,500 | 77,100 | 36,854 | 44.4 K to 36.9 K (-16.91 %) |
Oct 30 2017 | ENZ | ENZO BIOCHEM INC | O'Brien James Michael | EVP of Finance | Sell | S | 10.28 | 6,699 | 68,866 | 44,354 | 51.1 K to 44.4 K (-13.12 %) |
Oct 30 2017 | ENZ | ENZO BIOCHEM INC | O'Brien James Michael | EVP of Finance | Buy | M | 4.35 | 8,667 | 37,701 | 51,053 | 42.4 K to 51.1 K (+20.45 %) |
Oct 30 2017 | ENZ | ENZO BIOCHEM INC | O'Brien James Michael | EVP of Finance | Buy | M | 3.40 | 7,500 | 25,500 | 42,386 | 34.9 K to 42.4 K (+21.50 %) |
Oct 30 2017 | ENZ | ENZO BIOCHEM INC | O'Brien James Michael | EVP of Finance | Buy | M | 2.75 | 6,699 | 18,422 | 34,886 | 28.2 K to 34.9 K (+23.77 %) |
Oct 27 2017 | ENZ | ENZO BIOCHEM INC | WEINER BARRY W | President, CFO, Tre ... | Option Exercise | M | 3.00 | 112,500 | 337,500 | 215,596 | |
Oct 27 2017 | ENZ | ENZO BIOCHEM INC | WEINER BARRY W | President, CFO, Tre ... | Payment of Exercise | F | 10.11 | 33,449 | 338,169 | 1,335,792 | 1.4 M to 1.3 M (-2.44 %) |
Oct 27 2017 | ENZ | ENZO BIOCHEM INC | WEINER BARRY W | President, CFO, Tre ... | Sell | S | 10.11 | 54,126 | 547,214 | 1,369,241 | 1.4 M to 1.4 M (-3.80 %) |
Oct 27 2017 | ENZ | ENZO BIOCHEM INC | WEINER BARRY W | President, CFO, Tre ... | Buy | M | 3.00 | 112,500 | 337,500 | 1,423,367 | 1.3 M to 1.4 M (+8.58 %) |
Oct 27 2017 | ENZ | ENZO BIOCHEM INC | RABBANI ELAZAR | CEO, Chn. of the Br ... | Option Exercise | M | 3.00 | 159,091 | 477,273 | 260,754 | |
Oct 27 2017 | ENZ | ENZO BIOCHEM INC | RABBANI ELAZAR | CEO, Chn. of the Br ... | Payment of Exercise | F | 10.09 | 47,302 | 477,277 | 1,918,771 | 2 M to 1.9 M (-2.41 %) |
Oct 27 2017 | ENZ | ENZO BIOCHEM INC | RABBANI ELAZAR | CEO, Chn. of the Br ... | Sell | S | 10.09 | 72,401 | 730,526 | 1,966,073 | 2 M to 2 M (-3.55 %) |
Oct 27 2017 | ENZ | ENZO BIOCHEM INC | RABBANI ELAZAR | CEO, Chn. of the Br ... | Buy | M | 3.00 | 159,091 | 477,273 | 2,038,474 | 1.9 M to 2 M (+8.47 %) |
Jun 15 2017 | ENZ | ENZO BIOCHEM INC | O'Brien James Michael | EVP of Finance | Option Exercise | M | 3.40 | 2,500 | 8,500 | 75,200 | |
Jun 15 2017 | ENZ | ENZO BIOCHEM INC | O'Brien James Michael | EVP of Finance | Option Exercise | M | 2.75 | 13,300 | 36,575 | 77,700 | |
Jun 15 2017 | ENZ | ENZO BIOCHEM INC | O'Brien James Michael | EVP of Finance | Sell | S | 10.13 | 2,500 | 25,325 | 15,800 | 18.3 K to 15.8 K (-13.66 %) |
Jun 15 2017 | ENZ | ENZO BIOCHEM INC | O'Brien James Michael | EVP of Finance | Sell | S | 10.13 | 13,300 | 134,729 | 13,300 | 26.6 K to 13.3 K (-50.00 %) |
Jan 10 2017 | ENZ | ENZO BIOCHEM INC | WEINER BARRY W | President, CFO, Tre ... | Option Exercise | A | 7.07 | 65,000 | 459,550 | 328,096 | |
Jan 10 2017 | ENZ | ENZO BIOCHEM INC | BORTZ GREGORY M. | Director | Option Exercise | A | 7.07 | 41,632 | 294,338 | 299,087 | |
Jan 10 2017 | ENZ | ENZO BIOCHEM INC | Perlysky Dov | Director | Option Exercise | A | 7.07 | 41,632 | 294,338 | 299,087 | |
Jan 10 2017 | ENZ | ENZO BIOCHEM INC | RABBANI ELAZAR | CEO, Chn. of the Br ... | Option Exercise | A | 7.07 | 75,000 | 530,250 | 419,845 | |
Jan 10 2017 | ENZ | ENZO BIOCHEM INC | O'Brien James Michael | EVP of Finance | Option Exercise | A | 7.07 | 30,000 | 212,100 | 91,000 | |
Mar 18 2016 | ENZ | ENZO BIOCHEM INC | KASTEN BERNARD L | Director | Option Exercise | A | 4.66 | 63,291 | 294,936 | 257,455 | |
Mar 18 2016 | ENZ | ENZO BIOCHEM INC | KASTEN BERNARD L | Director | Sell | S | 4.41 | 6,954 | 30,674 | 0 | 7 K to 0 (-100.00 %) |
Mar 18 2016 | ENZ | ENZO BIOCHEM INC | KASTEN BERNARD L | Director | Sell | S | 4.39 | 3,100 | 13,597 | 6,954 | 10.1 K to 7 K (-30.83 %) |
Mar 18 2016 | ENZ | ENZO BIOCHEM INC | KASTEN BERNARD L | Director | Sell | S | 3.47 | 18,651 | 64,644 | 10,054 | 28.7 K to 10.1 K (-64.97 %) |
Mar 18 2016 | ENZ | ENZO BIOCHEM INC | KASTEN BERNARD L | Director | Sell | S | 4.40 | 9,720 | 42,739 | 28,705 | 38.4 K to 28.7 K (-25.30 %) |
Mar 18 2016 | ENZ | ENZO BIOCHEM INC | KASTEN BERNARD L | Director | Sell | S | 4.40 | 1,857 | 8,171 | 38,425 | 40.3 K to 38.4 K (-4.61 %) |
Mar 18 2016 | ENZ | ENZO BIOCHEM INC | KASTEN BERNARD L | Director | Sell | S | 4.66 | 2,500 | 11,640 | 40,282 | 42.8 K to 40.3 K (-5.84 %) |
Mar 16 2016 | ENZ | ENZO BIOCHEM INC | RABBANI ELAZAR | CEO, Chn. of the Br ... | Option Exercise | A | 4.35 | 60,000 | 261,000 | 147,249 | |
Mar 16 2016 | ENZ | ENZO BIOCHEM INC | O'Brien James Michael | SVP of Finance | Option Exercise | A | 4.35 | 26,000 | 113,100 | 61,000 | |
Mar 16 2016 | ENZ | ENZO BIOCHEM INC | GOLDBERG DAVID C | VP CorpDev IGM Enz ... | Option Exercise | A | 4.35 | 18,000 | 78,300 | 47,455 | |
Mar 16 2016 | ENZ | ENZO BIOCHEM INC | WEINER BARRY W | President, CFO, Tre ... | Option Exercise | A | 4.35 | 50,000 | 217,500 | 119,794 | |
Jan 21 2016 | ENZ | ENZO BIOCHEM INC | Perlysky Dov | Director | Option Exercise | A | 4.66 | 63,291 | 294,936 | 257,455 | |
Jan 21 2016 | ENZ | ENZO BIOCHEM INC | BORTZ GREGORY M. | Director | Option Exercise | A | 4.66 | 63,291 | 294,936 | 257,455 | |
Mar 24 2015 | ENZ | ENZO BIOCHEM INC | Perlysky Dov | Director | Buy | J | 0.00 | 40,872 | 0 | 40,872 | 0 to 40.9 K |
Mar 24 2015 | ENZ | ENZO BIOCHEM INC | Perlysky Dov | Director | Buy | J | 0.00 | 3 | 0 | 3 | 0 to 3 |
Mar 24 2015 | ENZ | ENZO BIOCHEM INC | Perlysky Dov | Director | Buy | J | 0.00 | 1,923 | 0 | 1,923 | 0 to 1.9 K |
Mar 24 2015 | ENZ | ENZO BIOCHEM INC | Perlysky Dov | Director | Sell | J | 0.00 | 416,589 | 0 | 109,237 | 525.8 K to 109.2 K (-79.23 %) |
Jan 23 2015 | ENZ | ENZO BIOCHEM INC | Perlysky Dov | Director | Option Exercise | A | 3.40 | 70,423 | 239,438 | 134,709 | |
Jan 23 2015 | ENZ | ENZO BIOCHEM INC | WEINER BARRY W | President, CFO, Tre ... | Option Exercise | A | 3.40 | 36,489 | 124,063 | 69,794 | |
Jan 23 2015 | ENZ | ENZO BIOCHEM INC | BORTZ GREGORY M. | Director | Option Exercise | A | 3.40 | 70,423 | 239,438 | 134,709 | |
Jan 23 2015 | ENZ | ENZO BIOCHEM INC | RABBANI ELAZAR | CEO, Chn. of the Br ... | Option Exercise | A | 3.40 | 45,615 | 155,091 | 87,249 | |
Jan 23 2015 | ENZ | ENZO BIOCHEM INC | KASTEN BERNARD L | Director | Option Exercise | A | 3.40 | 70,423 | 239,438 | 113,105 | |
Nov 13 2014 | ENZ | ENZO BIOCHEM INC | KASTEN BERNARD L | Director | Sell | S | 4.93 | 2,500 | 12,325 | 42,782 | 45.3 K to 42.8 K (-5.52 %) |
Nov 13 2014 | ENZ | ENZO BIOCHEM INC | KASTEN BERNARD L | Director | Sell | S | 4.94 | 5,000 | 24,705 | 45,282 | 50.3 K to 45.3 K (-9.94 %) |
Nov 13 2014 | ENZ | ENZO BIOCHEM INC | KASTEN BERNARD L | Director | Sell | S | 4.95 | 5,000 | 24,750 | 50,282 | 55.3 K to 50.3 K (-9.04 %) |
Nov 13 2014 | ENZ | ENZO BIOCHEM INC | KASTEN BERNARD L | Director | Sell | S | 4.91 | 333 | 1,634 | 55,282 | 55.6 K to 55.3 K (-0.60 %) |
Nov 13 2014 | ENZ | ENZO BIOCHEM INC | KASTEN BERNARD L | Director | Sell | S | 4.91 | 3,067 | 15,050 | 55,615 | 58.7 K to 55.6 K (-5.23 %) |
Jul 23 2014 | ENZ | ENZO BIOCHEM INC | KASTEN BERNARD L | Director | Sell | D | 5.01 | 12,498 | 62,615 | 64,847 | 77.3 K to 64.8 K (-16.16 %) |
Jul 23 2014 | ENZ | ENZO BIOCHEM INC | KASTEN BERNARD L | Director | Sell | D | 4.95 | 3,200 | 15,840 | 77,345 | 80.5 K to 77.3 K (-3.97 %) |
Apr 15 2014 | ENZ | ENZO BIOCHEM INC | KASTEN BERNARD L | Director | Sell | D | 4.17 | 7,500 | 31,275 | 80,545 | 88 K to 80.5 K (-8.52 %) |
Apr 03 2014 | ENZ | ENZO BIOCHEM INC | KASTEN BERNARD L | Director | Sell | D | 4.39 | 5,000 | 21,960 | 88,045 | 93 K to 88 K (-5.37 %) |
Apr 03 2014 | ENZ | ENZO BIOCHEM INC | KASTEN BERNARD L | Director | Sell | D | 3.99 | 2,500 | 9,985 | 93,045 | 95.5 K to 93 K (-2.62 %) |
Jan 22 2014 | ENZ | ENZO BIOCHEM INC | RABBANI ELAZAR | CEO | Option Exercise | A | 2.70 | 41,634 | 112,412 | 41,634 | |
Jan 22 2014 | ENZ | ENZO BIOCHEM INC | BASS HERBERT B | VP of Finance | Option Exercise | A | 2.70 | 12,273 | 33,137 | 12,273 | |
Jan 22 2014 | ENZ | ENZO BIOCHEM INC | Whiteley Andrew P | COO, Enzo Life Scie ... | Option Exercise | A | 2.70 | 12,273 | 33,137 | 12,273 | |
Jan 22 2014 | ENZ | ENZO BIOCHEM INC | GOLDBERG DAVID C | VP CorpDev IGM Enz ... | Option Exercise | A | 2.70 | 29,455 | 79,529 | 29,455 | |
Jan 22 2014 | ENZ | ENZO BIOCHEM INC | WEINER BARRY W | Pres., CFO | Option Exercise | A | 2.70 | 33,305 | 89,924 | 33,305 | |
Jan 22 2014 | ENZ | ENZO BIOCHEM INC | KASTEN BERNARD L | Director | Option Exercise | A | 2.70 | 64,286 | 173,572 | 64,286 | |
Jan 22 2014 | ENZ | ENZO BIOCHEM INC | BORTZ GREGORY M. | Director | Option Exercise | A | 2.70 | 64,286 | 173,572 | 64,286 | |
Jan 22 2014 | ENZ | ENZO BIOCHEM INC | Crescenzo Andrew R. | Senior VP of Financ ... | Option Exercise | A | 2.70 | 29,455 | 79,529 | 29,455 | |
Jan 22 2014 | ENZ | ENZO BIOCHEM INC | Perlysky Dov | Director | Option Exercise | A | 2.70 | 64,286 | 173,572 | 64,286 | |
Dec 18 2013 | ENZ | ENZO BIOCHEM INC | Crescenzo Andrew R. | Senior VP of Financ ... | Sell | D | 2.41 | 8,000 | 19,280 | 52,452 | 60.5 K to 52.5 K (-13.23 %) |
Dec 02 2013 | ENZ | ENZO BIOCHEM INC | WEINER BARRY W | Pres., CFO | Option Exercise | A | 3.00 | 112,500 | 337,500 | 112,500 | |
Dec 02 2013 | ENZ | ENZO BIOCHEM INC | RABBANI ELAZAR | CEO | Option Exercise | A | 3.00 | 159,091 | 477,273 | 159,091 | |
Jan 23 2013 | ENZ | ENZO BIOCHEM INC | Perlysky Dov | Director | Option Exercise | A | 2.88 | 59,455 | 171,230 | 59,455 | |
Jan 22 2013 | ENZ | ENZO BIOCHEM INC | BORTZ GREGORY M. | Director | Option Exercise | A | 2.88 | 59,455 | 171,230 | 59,455 | |
Jan 22 2013 | ENZ | ENZO BIOCHEM INC | KASTEN BERNARD L | Director | Option Exercise | A | 2.88 | 59,455 | 171,230 | 59,455 |